Thyrotoxic periodic paralysis is a sporadic muscle disorder characterized by episodic attacks of weakness associated with hypokalemia in individuals with hyperthyroidism. The paralysis resolves upon treatment of hyperthyroidism. The disorder is most common among males of Asian descent, ... Thyrotoxic periodic paralysis is a sporadic muscle disorder characterized by episodic attacks of weakness associated with hypokalemia in individuals with hyperthyroidism. The paralysis resolves upon treatment of hyperthyroidism. The disorder is most common among males of Asian descent, including Chinese, Japanese, Vietnamese, Filipino, and Koreans, although it occurs less commonly in individuals of Caucasian background. Thyrotoxic periodic paralysis is clinically similar to hereditary hypokalemic periodic paralysis (HOKPP; 170400), but the paralysis in TTPP occurs only in the presence of hyperthyroidism. TTPP can also be precipitated by factors that result in hypokalemia, such as carbohydrate ingestion and rest after exercise (review by Kung, 2006). - Genetic Heterogeneity of Thyrotoxic Periodic Paralysis See also TTPP2 (613239), conferred by variation in the KCNJ18 gene (613236) on chromosome 17p11, and TTPP3 (614834), mapped to chromosome 17q24.3.
Among 1,366 consecutive Southern Chinese patients with thyrotoxicosis, McFadzean and Yeung (1967) found that 25 had a history of 1 or more attacks of periodic paralysis, and that 23 of the 25 were male.
Bernard et ... Among 1,366 consecutive Southern Chinese patients with thyrotoxicosis, McFadzean and Yeung (1967) found that 25 had a history of 1 or more attacks of periodic paralysis, and that 23 of the 25 were male. Bernard et al. (1972) reported thyrotoxic periodic paralysis in 5 unrelated Californian males of Japanese, Mexican, and Filipino descent. The patients ranged in age from 18 to 36 years. All presented with a chief complaint of periodic muscle weakness and paralysis in the lower limbs, often occurring at night or in the morning or after a large meal. All were subsequently found to have variable clinical features of hyperthyroidism, including palpitations, hypertension, increased heart rate, nervousness, sweating, and weight loss. However, some of the patients had very mild features of hyperthyroidism. When measured, serum potassium was very low during the episodes. All patients had complete recovery after proper treatment for hyperthyroidism, and most had no significant family history. Bernard et al. (1972) noted that some patients may have subtle or even absent clinical signs of hyperthyroidism, which should be evaluated by laboratory studies. Layzer and Goldfield (1974) observed periodic paralysis in a Japanese-American male who 'abused' thyroid hormone. Ali (1975) reported a 30-year-old man of Scottish descent who presented with weight loss, palpitations, sweating, and heat intolerance over 18 months. He also reported episodic attacks of weakness in the legs that usually occurred after awakening, but could come at any time. He had no weakness between attacks. There was no relevant family history. Physical examination showed thyrotoxicosis, with exophthalmos, an enlarged thyroid gland, and hyperreflexia. During an attack, serum potassium was severely depleted and he had complete flaccid paralysis from the waist down associated with absent reflexes. Proper treatment of the hyperthyroidism resulted in complete clinical recovery with no further episodes of paralysis. Leung (1985) observed thyrotoxicosis and periodic paralysis in 4 adult members of a Chinese family: a mother and 3 children, including 2 males and 1 female. Two had Graves disease (275000) and Hashimoto thyroiditis (140300) as evidenced by the presence of thyroid antibodies and elevated thyroxine levels. The other 2 were not available for study. Kilpatrick et al. (1994) found 6 reports of thyrotoxic hypokalemic periodic paralysis in African Americans and described 4 additional cases, all in males. They concluded that the disorder may be more frequent in blacks than previously suspected and should be considered when patients present with unexplained hypokalemia, muscular weakness, and rhabdomyolysis.
Kung et al. (2004) studied 97 male patients with thyrotoxic periodic paralysis, 77 male Graves disease patients without thyrotoxic periodic paralysis, and 100 normal male subjects, all Chinese. They detected 12 single-nucleotide polymorphisms (SNPs) in the Cav1.1 gene ... Kung et al. (2004) studied 97 male patients with thyrotoxic periodic paralysis, 77 male Graves disease patients without thyrotoxic periodic paralysis, and 100 normal male subjects, all Chinese. They detected 12 single-nucleotide polymorphisms (SNPs) in the Cav1.1 gene (CACNA1S; 114208), 3 of which were novel. Significant differences in the SNP genotype distribution between subjects with thyrotoxic periodic paralysis compared with Graves disease controls and normal controls were seen at a 5-prime flanking region SNP (114208.0005) and 2 intronic SNPs (114208.0006, 114208.0007). The authors concluded that because these SNPs lie at or near a thyroid hormone-responsive element (TRE), it is possible that they may affect the binding affinity of the TRE and modulate the stimulation of thyroid hormone on the Cav1.1 gene. - Associations Pending Confirmation Dias Da Silva et al. (2002) identified an arg83-to-his (R83H; 604433.0001) substitution in the KCNE3 gene in 1 of 15 patients with thyrotoxic hypokalemic periodic paralysis. The patient was a 44-year-old Caucasian man of Portuguese descent who experienced episodic paralysis for 2 years before developing thyrotoxicosis caused by Graves disease (275000). Two of his 3 offspring, all asymptomatic, were found to have the same mutation. However, Sternberg et al. (2003) and Jurkat-Rott and Lehmann-Horn (2004) concluded that the R83H variant does not play a causative role in periodic paralysis and that it is a polymorphism. See 604433.0001 for further discussion. Tang et al. (2004) did not identify the R83H substitution, or any mutations in the KCNE3 gene, among 79 Chinese patients with thyrotoxic hypokalemic periodic paralysis.
The overall incidence of TTPP in Chinese and Japanese thyrotoxic patients had been estimated at 1.8 and 1.9%, respectively. In North America, the incidence is much lower, at about 0.1 to 0.2% in thyrotoxic patients. The male to ... The overall incidence of TTPP in Chinese and Japanese thyrotoxic patients had been estimated at 1.8 and 1.9%, respectively. In North America, the incidence is much lower, at about 0.1 to 0.2% in thyrotoxic patients. The male to female ratio ranges from 17:1 to 70:1 (review by Kung, 2006).